NO20082793L - Nye tiofenderivater - Google Patents
Nye tiofenderivaterInfo
- Publication number
- NO20082793L NO20082793L NO20082793A NO20082793A NO20082793L NO 20082793 L NO20082793 L NO 20082793L NO 20082793 A NO20082793 A NO 20082793A NO 20082793 A NO20082793 A NO 20082793A NO 20082793 L NO20082793 L NO 20082793L
- Authority
- NO
- Norway
- Prior art keywords
- thiophene derivatives
- new thiophene
- new
- derivatives
- immunosuppressants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Oppfinnelsen vedrører nye tiofenderivater, deres fremstilling og anvendelse som farmasøytisk aktive forbindelser. Nevnte forbindelser virker spesielt som immundempende midler.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2005053882 | 2005-11-23 | ||
PCT/IB2006/054388 WO2007060626A1 (en) | 2005-11-23 | 2006-11-22 | Novel thiophene derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082793L true NO20082793L (no) | 2008-06-20 |
Family
ID=37865763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082793A NO20082793L (no) | 2005-11-23 | 2008-06-20 | Nye tiofenderivater |
Country Status (16)
Country | Link |
---|---|
US (1) | US7981924B2 (no) |
EP (1) | EP1954688A1 (no) |
JP (1) | JP2009516735A (no) |
KR (1) | KR20080069228A (no) |
CN (1) | CN101312959A (no) |
AR (1) | AR057894A1 (no) |
AU (1) | AU2006318049A1 (no) |
BR (1) | BRPI0618871A2 (no) |
CA (1) | CA2629122A1 (no) |
IL (1) | IL191540A0 (no) |
NO (1) | NO20082793L (no) |
NZ (1) | NZ569102A (no) |
RU (1) | RU2420523C2 (no) |
TW (1) | TW200738670A (no) |
WO (1) | WO2007060626A1 (no) |
ZA (1) | ZA200805407B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4678139B2 (ja) * | 2004-05-10 | 2011-04-27 | トヨタ自動車株式会社 | 自動車の暖房制御システム |
WO2006010379A1 (en) * | 2004-07-29 | 2006-02-02 | Actelion Pharmaceuticals Ltd. | Novel thiophene derivatives as immunosuppressive agents |
KR20070116645A (ko) * | 2005-03-23 | 2007-12-10 | 액테리온 파마슈티칼 리미티드 | 스핑고신-1-포스페이트-1 수용체 길항제로서의 신규한티오펜 유도체 |
CA2602478A1 (en) | 2005-03-23 | 2006-09-28 | Actelion Pharmaceuticals Ltd | Novel thiophene derivatives |
KR101382733B1 (ko) | 2005-03-23 | 2014-04-14 | 액테리온 파마슈티칼 리미티드 | 면역조절물질로서의 수첨 벤조(c) 티오펜 유도체 |
KR20080024533A (ko) * | 2005-06-24 | 2008-03-18 | 액테리온 파마슈티칼 리미티드 | 신규한 티오펜 유도체 |
EP1979345B1 (en) | 2006-01-24 | 2009-11-04 | Actelion Pharmaceuticals Ltd. | Novel pyridine derivatives |
MX2009002233A (es) * | 2006-09-07 | 2009-03-16 | Actelion Pharmaceuticals Ltd | Derivados de piridin-4-il como agentes inmunomoduladores. |
AR061841A1 (es) * | 2006-09-07 | 2008-09-24 | Actelion Pharmaceuticals Ltd | Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores. |
KR101454937B1 (ko) * | 2006-09-08 | 2014-10-27 | 액테리온 파마슈티칼 리미티드 | 면역조절제로서 피리딘-3-일 유도체 |
EP2125797B1 (en) * | 2007-03-16 | 2014-01-15 | Actelion Pharmaceuticals Ltd. | Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
ES2403209T3 (es) * | 2007-12-10 | 2013-05-16 | Actelion Pharmaceuticals Ltd. | Derivados de tiofeno novedosos como agonistas de S1P1/EDG1 |
US20110028448A1 (en) * | 2008-03-06 | 2011-02-03 | Martin Bolli | Pyridine compounds |
PL2252609T3 (pl) * | 2008-03-07 | 2013-09-30 | Idorsia Pharmaceuticals Ltd | Pochodne pirydyn-2-ylu jako środki immunomodulujące |
PT2278960T (pt) | 2008-03-17 | 2017-03-09 | Actelion Pharmaceuticals Ltd | Regime de dosagem para um agonista seletivo do recetor s1p1 |
KR20220084423A (ko) | 2008-07-23 | 2022-06-21 | 아레나 파마슈티칼스, 인크. | 자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[b]인돌-3-일)아세트산 유도체 |
SI2342205T1 (sl) | 2008-08-27 | 2016-09-30 | Arena Pharmaceuticals, Inc. | Substituirani triciklični kislinski derivati kot agonisti S1P1 receptorja, uporabni v zdravljenju avtoimunskih in vnetnih obolenj |
SG178042A1 (en) | 2009-07-16 | 2012-03-29 | Actelion Pharmaceuticals Ltd | Pyridin-4-yl derivatives |
SG10201906876PA (en) | 2010-01-27 | 2019-09-27 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
SG10201501575VA (en) | 2010-03-03 | 2015-04-29 | Arena Pharm Inc | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
PT2665720E (pt) | 2011-01-19 | 2015-09-16 | Actelion Pharmaceuticals Ltd | Derivados de 2-metoxi-piridin-4-ilo |
PT2885266T (pt) | 2012-08-17 | 2020-05-29 | Actelion Pharmaceuticals Ltd | Processo para a preparação de (2z,5z)-5-(3-cloro-4-((r)-2,3-di-hidropropoxi)benzilideno)-2-(propilimino)-3-(o-tolil)tiazolidin-4-ona e intermediário utilizado no referido processo |
CN116850181A (zh) | 2015-01-06 | 2023-10-10 | 艾尼纳制药公司 | 治疗与s1p1受体有关的病症的方法 |
EP3298008B1 (en) | 2015-05-20 | 2019-11-20 | Idorsia Pharmaceuticals Ltd | Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol |
US10111841B2 (en) | 2015-06-19 | 2018-10-30 | University Of South Florida | Stabilization of alcohol intoxication-induced cardiovascular instability |
ES2929526T3 (es) | 2015-06-22 | 2022-11-29 | Arena Pharm Inc | Sal cristalina de L-arginina del ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para su uso en trastornos asociados al receptor S1P1 |
MA47504A (fr) | 2017-02-16 | 2019-12-25 | Arena Pharm Inc | Composés et méthodes de traitement de l'angiocholite biliaire primitive |
CA3053416A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations |
KR20210074291A (ko) | 2018-09-06 | 2021-06-21 | 아레나 파마슈티칼스, 인크. | 자가면역 및 염증성 장애의 치료에 유용한 화합물 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963557A (en) | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
AU7686891A (en) | 1990-04-05 | 1991-10-30 | American National Red Cross, The | A protein family related to immediate-early protein expressed by human endothelial cells during differentiation |
CA2051494C (en) | 1990-09-20 | 2006-03-14 | Robert J. Dinerstein | 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
US6423508B1 (en) | 1998-03-09 | 2002-07-23 | Smithkline Beecham Corporation | Polynucleotide sequences of human EDG-1c |
GB9808665D0 (en) * | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic compounds |
US20040058894A1 (en) | 2002-01-18 | 2004-03-25 | Doherty George A. | Selective S1P1/Edg1 receptor agonists |
EP1575964B1 (en) | 2002-01-18 | 2009-11-11 | Merck & Co., Inc. | N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
WO2003105771A2 (en) * | 2002-06-17 | 2003-12-24 | Merck & Co., Inc. | 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
WO2005014525A2 (en) | 2003-08-12 | 2005-02-17 | Mitsubishi Pharma Corporation | Bi-aryl compound having immunosuppressive activity |
KR101186386B1 (ko) * | 2003-08-29 | 2012-09-26 | 오노 야꾸힝 고교 가부시키가이샤 | S1p 수용체 결합능을 갖는 화합물 및 그 의약 용도 |
CN1859908A (zh) * | 2003-10-01 | 2006-11-08 | 默克公司 | 作为s1p受体激动剂的3,5-芳基、杂芳基或环烷基取代的-1,2,4-噁二唑类化合物 |
CN1894225A (zh) | 2003-12-17 | 2007-01-10 | 默克公司 | 作为鞘氨醇1-磷酸(内皮分化基因)受体激动剂的(3,4-二取代)丙酸酯 |
WO2006010379A1 (en) | 2004-07-29 | 2006-02-02 | Actelion Pharmaceuticals Ltd. | Novel thiophene derivatives as immunosuppressive agents |
KR101382733B1 (ko) | 2005-03-23 | 2014-04-14 | 액테리온 파마슈티칼 리미티드 | 면역조절물질로서의 수첨 벤조(c) 티오펜 유도체 |
KR20070116645A (ko) | 2005-03-23 | 2007-12-10 | 액테리온 파마슈티칼 리미티드 | 스핑고신-1-포스페이트-1 수용체 길항제로서의 신규한티오펜 유도체 |
CA2602478A1 (en) | 2005-03-23 | 2006-09-28 | Actelion Pharmaceuticals Ltd | Novel thiophene derivatives |
BRPI0612028A2 (pt) | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
KR20080024533A (ko) | 2005-06-24 | 2008-03-18 | 액테리온 파마슈티칼 리미티드 | 신규한 티오펜 유도체 |
EP1979345B1 (en) | 2006-01-24 | 2009-11-04 | Actelion Pharmaceuticals Ltd. | Novel pyridine derivatives |
GB0601744D0 (en) | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
-
2006
- 2006-11-15 AR ARP060105009A patent/AR057894A1/es not_active Application Discontinuation
- 2006-11-20 TW TW095142888A patent/TW200738670A/zh unknown
- 2006-11-22 JP JP2008541887A patent/JP2009516735A/ja active Pending
- 2006-11-22 EP EP06821533A patent/EP1954688A1/en not_active Withdrawn
- 2006-11-22 US US12/094,736 patent/US7981924B2/en not_active Expired - Fee Related
- 2006-11-22 KR KR1020087013370A patent/KR20080069228A/ko not_active Application Discontinuation
- 2006-11-22 WO PCT/IB2006/054388 patent/WO2007060626A1/en active Application Filing
- 2006-11-22 CN CNA2006800432916A patent/CN101312959A/zh active Pending
- 2006-11-22 RU RU2008125196/04A patent/RU2420523C2/ru not_active IP Right Cessation
- 2006-11-22 BR BRPI0618871-0A patent/BRPI0618871A2/pt not_active IP Right Cessation
- 2006-11-22 CA CA002629122A patent/CA2629122A1/en not_active Abandoned
- 2006-11-22 AU AU2006318049A patent/AU2006318049A1/en not_active Abandoned
- 2006-11-22 NZ NZ569102A patent/NZ569102A/en unknown
-
2008
- 2008-05-19 IL IL191540A patent/IL191540A0/en unknown
- 2008-06-20 ZA ZA200805407A patent/ZA200805407B/xx unknown
- 2008-06-20 NO NO20082793A patent/NO20082793L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200738670A (en) | 2007-10-16 |
JP2009516735A (ja) | 2009-04-23 |
CA2629122A1 (en) | 2007-05-31 |
US20080300294A1 (en) | 2008-12-04 |
NZ569102A (en) | 2011-06-30 |
RU2420523C2 (ru) | 2011-06-10 |
RU2008125196A (ru) | 2009-12-27 |
KR20080069228A (ko) | 2008-07-25 |
AU2006318049A1 (en) | 2007-05-31 |
ZA200805407B (en) | 2009-12-30 |
US7981924B2 (en) | 2011-07-19 |
CN101312959A (zh) | 2008-11-26 |
WO2007060626A1 (en) | 2007-05-31 |
AR057894A1 (es) | 2007-12-26 |
BRPI0618871A2 (pt) | 2011-09-13 |
IL191540A0 (en) | 2008-12-29 |
EP1954688A1 (en) | 2008-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082793L (no) | Nye tiofenderivater | |
NO20075298L (no) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
NO20091395L (no) | Nye tiofenderivater | |
NO20076648L (no) | Novel thiophene derivatives | |
NO20071095L (no) | Hittil ukjente tiofenderivater | |
NO20083462L (no) | Nye tiofenderivater som S1P1/EDG1-reseptoragonister | |
NO20083630L (no) | Nye pyridinderivater | |
NO20075299L (no) | Hydrogenated benzo (c) thiophene derivatives as immunomodulators | |
MX2010005889A (es) | Derivados de tiofeno como agonistas de s1p1/edg1. | |
NO20093146L (no) | Amino-pyridinderivater som S1P1/EDG1-reseptoragonister | |
TW200716552A (en) | Novel thiophene derivatives | |
LTPA2016036I1 (lt) | Nitrokatechnolio dariniai, kaip COMT inhibitoriai | |
MX2010004576A (es) | Derivados de pirimidina novedosos. | |
NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
NO20090295L (no) | Substituerte heteroarylderivater | |
DK1902037T3 (da) | 2,4-diamino-pyrimidiner som auroainhibitorer | |
DK1881967T3 (da) | Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika | |
DK1846394T3 (da) | Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer | |
DK1928840T3 (da) | 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer | |
EA200601686A1 (ru) | Замещенные производные морфолина и тиоморфолина | |
NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
EA201170703A1 (ru) | Производные адамантилбензамида | |
DK2051975T3 (da) | Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel. | |
NO20091299L (no) | Substituerte sulfonamidderivater | |
TW200942524A (en) | Novel aminomethyl benzene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |